Section Arrow
Quote
VRAX.NASDAQ
- Virax Biolabs Group Limited
(Financial Status)
Quotes are at least 15-min delayed:2024/05/16 18:19 EDT
Last
 0.7836
-0.0014 (-0.18%)
Day High 
0.82 
Prev. Close
0.785 
1-M High
0.84 
Volume 
22.77K 
Bid
0.77
Ask
0.81
Day Low
0.77 
Open
0.79 
1-M Low
0.6 
Market Cap 
1.85M 
Currency USD 
P/E -- 
%Yield 0 
10-SMA 0.72 
20-SMA 0.69 
50-SMA 0.76 
52-W High 5.445 
52-W Low 0.6 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-17.70/--
Enterprise Value
1.85M
Balance Sheet
Book Value Per Share
2.68
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
8.56K
Operating Revenue Per Share
0.00
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
SCPXScorpius Holdings0.1001+0.0224+28.83%-- 
DNAGinkgo Bioworks Holdings0.839-0.0001-0.01%-- 
NBYNovaBay Pharmaceuticals0.12+0.0155+14.83%-- 
JAGXJaguar Health0.2867+0.0316+12.39%-- 
NVAXNovavax14.4+1.5+11.63%-- 
Quotes are at least 15-min delayed：2024/05/16 18:19 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Virax Biolabs Group Ltd is a innovative biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against major global viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.